A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2032849
下载链接
链接失效反馈官方服务：
资源简介：
This study is intended to provide access to tremelimumab for patients who have previously received tremelimumab in a clinical trial.
创建时间：
2007-03-15
